EUVIMEDEUVIMED entdecken
Crossref

Lycopene protects against acute kidney injury by suppressing PARP/NOTCH-mediated inflammation

Xiao-Wei Hu, Yu-Qing Wang, Xiang-Yu Li, Xiao-Yu Shen, Run-Run Shan, Ju-Tao Yu, He-Ping Cai, Xiao-Ming Meng, Qin Yang

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2025.116136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Xiao-Wei Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Anhui Provincial Children's Hospital, No. 39, East Wangjiang Road, Anhui Province, Hefei 230000, China. Hauptthemen laut MEDLINE: Lycopene, Acute Kidney Injury, Poly (ADP-Ribose) Polymerase-1, Anti-Inflammatory Agents. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Provincial Natural Science Foundation, Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury (AKI) is a clinical syndrome caused by diverse etiologies. It is characterized by a rapid decline in renal function, marked increases in serum creatinine and urea nitrogen levels, and excessive recruitment of inflammatory cells. Although lycopene exhibits notable anti-inflammatory properties, its specific mechanism of action and therapeutic potential in AKI remains to be elucidated. PARP1, which plays a role in DNA repair, chromatin regulation, gene expression, ribosomal biogenesis, and mRNA metabolism, has been implicated in the progression of AKI. In this study, we aimed to investigate the protective effects of lycopene in AKI models and elucidate its underlying mechanisms, focusing on its anti-inflammatory effects and targeted inhibition of PARP1. The protective effects of lycopene were tested in two AKI mouse models established using male C57BL/6 J mice, following a single intraperitoneal injection of cisplatin or renal ischemia-reperfusion (IRI) for 40 min. Renal function, tubular injury, and inflammation were assessed. In addition, the renoprotective effects of lycopene were evaluated in cisplatin- and hypoxia-treated tubular epithelial cells. The mechanisms underlying these effects were explored using RNA sequencing. In vivo, lycopene substantially suppressed the increase in serum creatinine and blood urea nitrogen levels. Moreover, lycopene alleviated tubular damage, as shown by periodic acid-Schiff staining and molecular analysis of KIM-1. These anti-inflammatory effects were further confirmed in vitro. Mechanistically, RNA sequencing revealed that lycopene markedly suppressed the Notch pathway by targeting PARP1. Lycopene may serve as a potential therapeutic agent for AKI treatment via PARP1/Notch-dependent mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LycopeneAcute Kidney InjuryPoly (ADP-Ribose) Polymerase-1Anti-Inflammatory AgentsAnimalsMaleMice, Inbred C57BLMiceReceptors, NotchDisease Models, AnimalCisplatinSignal TransductionInflammationHumansReperfusion InjuryCell LineKidney

Stichwörter der Autor:innen

AKIInflammationLycopeneNotch1PARP1

Substanzen

LycopenePoly (ADP-Ribose) Polymerase-1Anti-Inflammatory AgentsReceptors, NotchCisplatinParp1 protein, mouse

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Anhui Provincial Children's Hospital, No. 39, East Wangjiang Road, Anhui Province, Hefei 230000, China.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of AntiInflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmaceutical Sc…
  • Department of Clinical Pharmacy, Anhui Provincial Children's Hospital, No. 39, East Wangjiang Road, Anhui Province, Hefei 230000, China. Electronic address: greenhprui@163.com.
  • Department of Clinical Pharmacology, Second Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, Anhui, China. Electronic address: yangqin@fy.ahmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Anhui Provincial Natural Science Foundation
  • Anhui Medical University

Zitieren

APA

Hu, X. W., Wang, Y. Q., Li, X. Y., Shen, X. Y., Shan, R. R., Yu, J. T., Cai, H. P., Meng, X. M., & Yang, Q. (2026). Lycopene protects against acute kidney injury by suppressing PARP/NOTCH-mediated inflammation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.116136

Vancouver

Hu XW, Wang YQ, Li XY, Shen XY, Shan RR, Yu JT, et al. Lycopene protects against acute kidney injury by suppressing PARP/NOTCH-mediated inflammation. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2025.116136

BibTeX
@article{Hu2026,
  author = {Hu, Xiao-Wei and Wang, Yu-Qing and Li, Xiang-Yu and Shen, Xiao-Yu and Shan, Run-Run and Yu, Ju-Tao and Cai, He-Ping and Meng, Xiao-Ming and Yang, Qin},
  title = {Lycopene protects against acute kidney injury by suppressing PARP/NOTCH-mediated inflammation},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2025.116136}
}
Kostenlos starten →